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A B S T R A C T
Purpose: This UK-wide review of deaths in children with epilepsies was undertaken to ascertain any
demographic, clinical, organisational, or management factors associated with the deaths, and to determine
the extent to which any of these may have deviated from nationally agreed best practice.
Method: Paediatricians across the UK were asked to notify any deaths in children with epilepsies over a
10-month period. Hospital and community case notes were reviewed by pairs of case assessors using a
structured assessment tool combining holistic and criterion-based approaches.
Results: Of 46 deaths notiﬁed, case notes were obtained on 33. The majority of children had associated
developmental impairments. The majority (24), died of an associated co-morbidity rather than of
epilepsy. Seven died of convulsive status epilepticus and seven as sudden unexpected deaths in epilepsy.
Twenty four percent of deaths were judged to be preventable; potentially modiﬁable factors included
fragmentation of care, support for families, and recognition of and response to acute illness in the child,
including the appropriate management of prolonged seizures.
Conclusions: Although this audit has demonstrated signiﬁcant improvements in quality of care when
compared with the last national audit of epilepsy deaths in 2002, further improvement is still required.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Epilepsies are some of the most common chronic neurological
conditions of childhood, with an estimated prevalence of 4.3 per
1000 children [1,2]. This equates to an estimated 65,000 children
and young people with active epilepsy living in the UK. An average
57 children and young people aged <18 years die each year in the
UK with epilepsy recorded as the underlying cause of death, and a
further 55 registered deaths cite epilepsy as an underlying
condition on the death certiﬁcate (Ruth Gilbert, Pia Hardelid,
personal communication). Epilepsy-related deaths may occur as a
direct result of the seizure (including convulsive status epilepti-
cus), as a consequence of treatment given for the epilepsy, as an
accident (including drowning), as sudden unexpected death in
epilepsy (SUDEP), or may be related to an associated underlying
neurological problem or arise from an unrelated cause.
Some epilepsy-related deaths are likely to be unavoidable, but
others may relate to deﬁciencies in the care provided to children
and their families. A previous national audit in 2002 concluded that* Corresponding author. Tel.: +44 24 7657 4878.
E-mail address: p.sidebotham@warwick.ac.uk (P. Sidebotham).
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights re59% of epilepsy-related child deaths were potentially avoidable [3].
This was particularly related to limited access to specialist
paediatric neurology expertise and the use of potentially
inappropriate anti-epileptic medication. Since the publication of
this National Sentinel Audit, a number of initiatives have focussed
on the improvement of care of people of all ages with epilepsies [4],
including the publication of national guidelines for the manage-
ment of epilepsies [5–7]. A recent review of services for children
with epilepsies [4] identiﬁed a number of improvements in overall
care of these children, ﬁndings echoed in the 2012 national
‘Epilepsy 12’ audit [8]. However, there has been no more recent
national review of epilepsy deaths, and recent high-proﬁle cases
suggest that poor quality of care may still be contributing to the
deaths of some children with epilepsies [9].
As part of a national review of the quality of healthcare for
children and young people with epilepsies, we sought to evaluate
the case records of all reported deaths in children and young
people with epilepsies across the UK between June 2012 and
March 2013 [10]. The aim of the review was to ascertain any
demographic, clinical, organisational or management factors
associated with these deaths, and to determine the extent to
which any of these deaths may have been associated with
divergence from nationally agreed best practice. It was anticipatedserved.
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practice, could be used to promote good quality care and to make
recommendations for the provision of services to children and
young people with epilepsies.
2. Methods
The review used a mixed-methods approach, incorporating
questionnaire-based demographic and clinical data, and a case
notes review combining an explicit criterion-based assessment of
clinical care with a more in-depth holistic review [11]. The review
included any child or young person aged from 1 year and up to
their eighteenth birthday with a prior diagnosis of epilepsy who
died of any cause (Box 1). The time period for the review was 1 June
2012 to 31 March 2013. The time period for notiﬁcation was
limited by the requirements of the commissioning bodies.
Currently in the UK there is no national registry of epilepsy,
although a voluntary epilepsy deaths register was established in
2013 by SUDEP Action (www.sudep.org/article/epilepsy-
deaths-register). However, national guidance speciﬁes that ‘the
diagnosis of epilepsy in children and young people should be
established by a specialist paediatrician with training and expertise
in epilepsy’ [5]. While there may be small numbers of older young
people managed solely by general practitioners or adult neurology
services, in practice nearly all, and certainly all complex cases are
managed by paediatricians. All consultant paediatricians across the
UK were e-mailed on a monthly basis and asked to notify the team of
any cases they had seen in the previous month. For each reported
case, the consultant was asked to complete a secure web-based
questionnaire providing demographic and clinical details. In order to
maximise case ascertainment the study was advertised widely so
others could notify cases, including intensive care units and child
death overview panels, and a data-sharing agreement was set up
with PICANet, a national paediatric intensive care audit network.Box 1. Inclusion criteria and definitions.
Inclusion criteria
a. A child or young person with epilepsy who has died, of any cause
OR
b. A child or young person that has received intensive care or high
dependency care following a prolonged seizure
AND
c. The child or young person was aged between their ﬁrst and 18th
birthdays at the time of the incident
AND
d. Prior to the incident the child or young person had a diagnosis of
epilepsy.
Deﬁnitions
A pragmatic deﬁnition for epilepsy was used in this review: ‘two or
more epileptic seizures more than 24 h apart that are not acute
symptomatic seizures or febrile seizures’. For the purposes of this
review, any child or young person was included for whom the
reporting clinician considered there to have been a previous
diagnosis of epilepsy based on that deﬁnition.
Prolonged seizures were deﬁned as ‘any tonic–clonic seizure lasting
longer than 5 min, or serial, repeated seizures continuing over a
period of more than 30 min’.
Intensive care was deﬁned as any child or young person requiring
admittance to an intensive care unit, or receiving an equivalent
level of care.
High dependency care was deﬁned as requiring ‘on-going close
intervention or monitoring because of neurological or cardio-
respiratory compromise’. This will include any child or young person
receiving care requiring a nurse to patient ratio of 0.5:1 (1:1 in
cubicle), and any child or young person requiring at least hourly
neurological or cardio-respiratory observations.For each notiﬁed case, the case notes were requested from the
child’s ﬁrst seizure through to the death, incorporating records
from primary, secondary and tertiary care settings. Each set of case
notes was reviewed by a pair of case assessors comprised of a
paediatric nurse and a paediatrician who were actively involved in
the care of children with epilepsies, and had undergone training in
epilepsy care. None of the case assessors had been involved with
the care of the children prior to, or following their death. The case
assessors were trained in case notes review methodology and were
supported by the research team, with regular brieﬁng meetings
and the opportunity to discuss any queries that arose from their
review. The case assessment tool was structured around six phases
of care (initial diagnosis and management; ongoing management;
pre-hospital care; emergency department care; intensive or high
dependency care; and care of the child and family around and
following the death). The tool included a criterion-based assess-
ment using recognised clinical standards [5,7,12,13], and a
structured implicit review in which the case assessors were asked
to rate the quality of care in each phase and to comment on any
learning points and identiﬁed avoidable or remediable factors;
they were also tasked with the identiﬁcation of elements of good
clinical practice and care. Details of the case assessment tools and
their development are provided in the full CHR-UK report and in
Appendix 1 [10]. Case assessors were required to classify the cause
of death, according to a structured proforma (Appendix 2) and each
case was reviewed by the lead researcher (PS) to conﬁrm the
classiﬁcation of the death.
Ethical advice on the review was sought from the National
Research Ethics Service. As a national service evaluation, the
review was granted National Information Governance Board 251
approval to collect patient identiﬁable data without consent, along
with equivalent approvals from the Scotland Caldicott Guardian
and the Northern Ireland Privacy Advisory Committee. All patient-
identiﬁable data were removed from the database prior to analysis
by the research team.
3. Results
A total of 46 deaths in children with epilepsies were notiﬁed to
the study. Hospital and community case notes were obtained for
detailed review on 33 children. In spite of repeated attempts, case
notes for the remaining 13 children were not provided by the
hospital or community health providers. Details of the 46 children
are shown in Table 1. The majority (94%) were known to have
associated co-morbid conditions, including developmental impair-
ments, most of which were severe and required multi-disciplinary
care. Thirty-one children (67%) had a recognised cause for their
epilepsy, of which the most common were identiﬁed genetic
disorders [10], hypoxic-ischaemic neonatal brain injury [7], and
cerebral malformations [6]. Eight children (17%) had an identiﬁed
epilepsy syndrome, including West, Dravet, a progressive myo-
clonic epilepsy, Lennox Gastaut, epilepsy with generalised tonic–
clonic seizures on awakening, and epilepsy with myoclonic
absences.
The majority of children (29/46, 63%) were at home when they
died or at the start of the incident that led to their death; 23 of
these were transferred to hospital, including seven who received
intensive or high dependency care for a prolonged seizure prior to
their death. Five children were already in a hospice at the time of
their death and a further four were transferred to a hospice for end
of life care. Sixteen children (35%) were experiencing at least
weekly seizures prior to their death, although these rarely
necessitated a hospital attendance. Seven children (15%) had been
admitted to hospital with a prolonged seizure (usually tonic–
clonic) in the previous 12 months.
Table 1
Characteristics of children in the review.
Characteristic Number (percent)
Total reported
N = 46a
Included in case
notes review
N = 33a
Gender Male 25 (54) 19 (58)
Female 21 (46) 14 (42)
Age group (years) 1–4 19 (41) 15 (45)
5–9 12 (26) 8 (24)
10–14 11 (24) 7 (21)
15–17 4 (9) 3 (9)
Ethnicity White 32 (73) 23 (72)
Non-white 12 (27) 9 (28)
Country of origin England 33 (72) 25 (76)
Scotland 5 (11) 3 (9)
Wales 5 (11) 3 (9)
Northern
Ireland
3 (7) 2 (6)
Deprivation
quintileb
1 (most
deprived)
7 (24) 6 (26)
2 7 (24) 4 (17)
3 8 (28) 7 (30)
4 3 (10) 3 (13)
5 (least
deprived)
4 (14) 3 (13)
Concurrent
disability
43 (94) 32 (97)
a Percentages based on the number for whom data were available.
b Based on the index of multiple deprivation for the postcode of the child’s
residence.
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there was evidence that a paediatric neurologist or paediatrician
with expertise in epilepsy had been involved in the initial diagnosis
or ongoing follow-up of the child. In 14 cases (42%) there was
evidence of previous involvement of an epilepsy specialist nurse. In
two children, there was evidence of inappropriate medication use
in the 6 months prior to the child’s death. In one, a child with
poorly controlled absence and generalised tonic–clonic seizures,Table 2
Cause of death.
Classiﬁcation Number (%) Comments
Death from a cause unrelated
to the epilepsy
2 (4) Two children died
were also reporte
the cause of deat
Death from a co-morbidity
associated with the
epilepsy
24 (52) Mostly these we
respiratory failur
of pneumonia or
Batten’s disease, 
leukodystrophy; 
remaining childr
or from a cardiac
Death as a consequence of
treatment given for
epilepsy
1 (2) One child died of 
anti-epileptic dru
epilepsy.
Trauma associated with a
seizure
0 (0) There were no ch
indicated that th
Death secondary to status
epilepticus
7 (15) This category wa
status epilepticus
during which the
SUDEP 7 (15) This classiﬁcation
unwitnessed, non
individual with e
epilepticus.
There were two c
conﬁrmed no alte
autopsy results a
Unknown 5 (11) In ﬁve cases ther
able to classify thsodium valproate had been increased to a dose higher than that
recommended in the British National Formulary for Children
(BNFc) before trying a second anti-epileptic drug. This child died of
a complication of his underlying neurodisability. The second child,
who died as a SUDEP, was receiving four anti-epileptic drugs,
which had been frequently changed over the past few months and
there was a lack of clarity over which clinician (consultant
paediatrician or paediatric neurologist) was taking overall
responsibility for the medication reviews.
The cause of death as determined by a detailed and careful
review of the clinical notes is given in Table 2. In ﬁve cases there
was insufﬁcient information in the case notes or questionnaire to
be able to classify the death. The majority of children died of causes
other than their epilepsy. Most deaths were of children with
complex co-morbidities who died of respiratory infections or
respiratory failure directly associated with their underlying
disability, most notably severe quadriplegic cerebral palsy
secondary to prematurity. For many of these children the death
was anticipated and an end of life care plan or other palliative care
measures had been put in place prior to death. The two children
who died of unrelated causes (one chronic medical condition and
one acute surgical condition) also had recognised developmental
impairments. There was one child for whom a recognised
complication of their anti-epileptic treatment was identiﬁed and
considered a possible cause of death (intracranial haemorrhage
presumed secondary to marked thrombocytopaenia). The seven
children who died in an episode of convulsive status epilepticus
had suffered a cardiac or respiratory arrest during the seizure and
either could not be resuscitated or died from subsequent multi-
organ failure. Three of these seven children had been experiencing
at least weekly tonic or tonic–clonic seizures, but four were
considered to be well-controlled with a tonic–clonic seizure
frequency of less than one a month and no hospital admission
within the preceding 12 months.
Of the seven children classiﬁed as SUDEP, two satisﬁed the
criteria for deﬁnite SUDEP (i.e. autopsy reports were available in
the notes) and ﬁve for probable SUDEP [14]. All seven were found
in their beds by their parent or carers, following a period of of conditions unrelated to their epilepsy, one surgical, one medical. Both children
d to have associated developmental impairments, but these were not related to
h.
re children with complex co-morbidities who died of respiratory infections/
e in association with their co-morbidities. Six children had cerebral palsy and died
 respiratory failure. Ten had other deﬁned neurological conditions including
lissencephaly, Leigh’s disease, Rett syndrome, Alpers syndrome and
these children died as a result of pneumonia, sepsis or multi-organ failure. The
en had unspeciﬁed complex neurodisability and died either of pneumonia/sepsis,
 arrest.
a cause secondary to low platelets, a recognized side effect of the child’s prescribed
gs. This was therefore classiﬁed as a possible consequence of a treatment given for
ildren in whom the clinical questionnaire or review of the clinical records
e child had died as a consequence of trauma associated with a seizure.
s used for all children in whom there was documented evidence of convulsive
 (continuous, convulsive seizures lasting at least 30 min, or two or more seizures
 child does not return to baseline consciousness).
 was used if the case met the criteria of a sudden, unexpected, witnessed or
-traumatic and non-drowning death, occurring in benign circumstances, in an
pilepsy, with or without evidence of a seizure and excluding documented status
ases that satisﬁed the criteria for deﬁnite SUDEP (i.e. autopsy results available and
rnative cause of death) and ﬁve for probable SUDEP (met clinical criteria, but no
vailable for conﬁrmation).
e was insufﬁcient information in the case notes and clinical questionnaire to be
e death.
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impairments. Five children were receiving at least two anti-
epileptic drugs, had been experiencing daily seizures, and had
required at least one hospital admission in the preceding 12
months. The remaining two children were receiving a single anti-
epileptic drug and were not reported to have experienced frequent
seizures in the months prior to their death.
The paired case-assessors determined that 8/33 deaths (24%)
were preventable according to the deﬁnition used by English Child
Death Overview Panels: ‘A death is considered preventable if the
assessor has identiﬁed one or more factors, in any domain, which
may have contributed to the death of the child and which, by
means of locally or nationally achievable interventions, could be
modiﬁed to reduce the risk of future child deaths’[15]. Factors that
were considered to have contributed to these deaths related to
fragmentation of care, appropriate support for families in
responding to emergencies, and hospital responses to the acutely
unwell child, including those presenting with convulsive status
epilepticus (Table 3).
In 16 cases (48%), the case-assessors identiﬁed gaps in the
quality of care provided where it had fallen short of current best
practice in one or more signiﬁcant areas, although the gaps were
not necessarily considered to have contributed to the child’s death
(Table 4). These included cases where an appropriate specialist had
not been involved in the initial diagnosis; anti-epileptic drugs had
not been administered according to agreed protocols; there was no
clear emergency care plan; or where there was poor communica-
tion between professionals and family. In 11 cases, there were gaps
in the quality of care in more than one area. Further evidence of
gaps in the quality of care was provided in relation to the individual
standards of care measured. Compliance with these is documented
in Table 5.
Eighteen children had a recognised life-limiting condition. In 17
(94%), there was documented evidence that the child’s prognosis
had been discussed with the family, and in 12 (67%) there was a
documented and agreed end of life care plan.
The poor quality of record-keeping following the child’s death
meant that, in nearly all cases, it was difﬁcult to determine what
actions had taken place in relation to any investigation or
classiﬁcation of the cause of death, onward referral, family support
or case review. In 19 (58%) children, there was evidence that an
appropriately trained clinician had taken a clinical history,
examined the child, and arranged for appropriate investigationsTable 3
Modiﬁable factors which may have contributed to death.
Issue Case assessors’ examples from the case review
Fragmentation of care ‘Child seen with a respiratory infection a week b
‘In relation to service provision, there was no paed
chest deterioration at home, i.e. with use of antibi
Multiple professionals involved but no coordinat
‘The care of the child lacked cohesion and appear
paediatrician was very involved there were aspec
Support for families ‘Child had been unwell on the evening prior to adm
appeared to recognise that her child was very un
‘The family is from overseas and have some limited
over a long period of time’.
‘The child had been seen in hospital the day before
been given to the family’.
Hospital responses
to the acutely
unwell child
‘There were identiﬁed delays in appropriate man
emergency department. There were long delays b
anaesthetist and deﬁnitive treatment started to b
hypotensive. A focus on controlling the seizures m
‘The child had a cardio-respiratory arrest and wa
recognise the seriousness of the child’s condition
‘There was a failure to manage status epilepticus
manage the airway and induce anaesthesia, leadieither before or after the child’s death. Seventeen cases had been
referred to a coroner or procurator ﬁscal. In ﬁve cases there was
evidence that an autopsy had been carried out, but there was rarely
any record of the outcome of the autopsy in the clinical notes. In
four cases there was documented evidence of a case discussion or
child death review following the death. In 19 (58%) cases there was
evidence that the family had been offered support from healthcare
professionals following the death, through letters to the parents,
home visits, follow up appointments, or a combination of all three.
4. Discussion
This review is the ﬁrst UK-wide review of children’s epilepsy
deaths since the 2002 National Sentinel Audit [3] and follows
considerable national initiatives to improve the quality of care for
children with epilepsies, including the publication of national
guidelines for epilepsy care [4–7]. As a nationally commissioned
review, we were able to ensure full coverage from all four devolved
nations of the UK. In spite of our efforts to ensure comprehensive
reporting, one of the weaknesses of the study was in relying
primarily on paediatricians as the sole source of notiﬁcation. The
numbers reported were lower than expected over this time period.
Nevertheless, the ﬁndings were clinically relevant, and it is likely
that similar learning would have emerged had more cases been
reported to the study. Robust methods that combined explicit
criterion-based assessments with a structured holistic review
highlighted examples of good practice but also clearly identiﬁed
factors that could further improve the care of children with
epilepsy.
Overall, this review demonstrates an improved quality of care
when compared with the ﬁndings of the National Sentinel Audit.
This review has shown that children and young people with
epilepsy are generally being well managed, with good, holistic and
supportive care, and reﬂects our earlier ﬁndings on the quality of
care following prolonged seizures [16], and those of the ‘Epilepsy
120 audit [8].
The ﬁgure of 24% of deaths being assessed as preventable is
similar to other, wider reviews of children’s deaths from all causes
[17]. It is considerably lower than the 59% of deaths deemed
potentially avoidable in 2002 [3]. Two ﬁndings stand out in this
respect: inadequate access to specialist care (consultant paedia-
trician or paediatric neurologist) was identiﬁed in 8/22 (36%)
children in the 2002 audit, and inadequate anti-epileptic drugefore death following a prolonged seizure. No review of AED undertaken’.
iatrician in charge of overall care. No evidence of a hospital care plan, no plan for
otics. No epilepsy review for 18 months before death despite medication changes.
or of care’.
ed fragmented due to the multiple specialists involved. Although the consultant
ts of care that were delivered in isolation’.
ission – mother had not sought advice but phoned the ward the next day. Had not
well. Took child to hospital on a bus rather than call ambulance’.
 English. It seems they are a hard to reach family. There were missed appointments
 her collapse and was noted to be unwell, but it was not clear what information had
agement of this child’s status epilepticus both in the community and in the
efore the child received any benzodiazepines and before the child was seen by an
ring the seizures under control. During this time the child had been hypoxic and
eant that the airway, breathing and circulation had not been adequately secured’.
s found unconscious on the general paediatric ward. There had been failure to
 at an earlier stage and despite regular monitoring’.
 according to NICE Guidelines, and there was no availability of anaesthetist to
ng to the child having a cardiac arrest’.
Table 4
Identiﬁed gaps in the provision of care.
Phase of care Numbera (%) of cases
with identiﬁed gaps
in provision of care
Initial diagnosis and management 10/28 (36)
Ongoing management 10/32 (31)
Pre-hospital care 5/20 (25)
Emergency department care 3/14 (21)
Intensive/high dependency care 0/3 (0)
a The denominator is based on the number of cases for which the assessors were
able to rate the quality of care in this phase; children who died in the community or
did not receive emergency or intensive/high dependency care are excluded from
those ﬁgures.
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doses, or no drug prescribed) in 10/22. In contrast, 85% of children
in our audit had access to specialist care, and in only two was there
evidence of inappropriate anti-epileptic drug management. The
drug management of epilepsies is complex; there will inevitably be
some situations, particularly in more complex cases, where it is
appropriate to deviate from published guidelines, for example
through using higher than recommended doses, or an alternative
medication. We noted some cases where non-standard treatment
had been used and the reasons for this clearly documented in the
notes. In other cases, however, there was nothing in the notes to
indicate why recommended practice had not been followed.
Nevertheless, in spite of the overall improvements in the
quality of care, the fact that nearly one in four deaths were judged
to be preventable precludes complacency. Furthermore, even in
those children whose deaths were not considered preventable, a
signiﬁcant proportion had identiﬁed gaps in one or more aspects of
the care pathway. These primarily related to fragmentation of care
in children with multiple, complex needs; communication with
and support for families; and the recognition of and response to
acute illness.
Similar to previous reports, the majority of children in this
review had concurrent co-morbidities, highlighting that deaths are
more likely in children with complex neuro-disability. The
majority of these children died of co-morbidities rather than of
the epilepsy. These children often have complex needs requiring
multi-disciplinary health input, along with support from education
and social care. With many professionals involved, it is easy for
different aspects of the child’s care to be fragmented, with the
potential for critical elements of care to be neglected or dealt with
in isolation. This was particularly noted when children were
admitted to hospital with prolonged seizures where information
about the admission and any changes to anti-epileptic treatment
(both maintenance and emergency) was not shared with the
clinicians involved in the child’s ongoing care. Communication
between different clinical teams, particularly across hospital and
community settings is crucially important. Such communication
could be aided by the use of a parent or carer-held ‘epilepsy
passport’, such as is used in the care of people with diabetes [18].
Clear and effective coordination of care is recognised as a priority
in both the NICE and SIGN national guidelines, and is supported by
having a named clinician with overall responsibility for the child’s
care, and also by the involvement of epilepsy specialist nurses.
Although there has been a limited increase in the number of
epilepsy specialist nurses, this service was absent in more than half
of the children.
Communication with families was highlighted as an important
issue in the 2002 Sentinel Audit [3] and continued to be a very
common theme in all of our deaths where there were identiﬁed
failings in care. This was particularly prominent in relation to
children who attended hospital with a prolonged seizure or acuteillness, but were considered well enough to go home, or were
discharged after a period of observation. In a number of cases there
was minimal documentation of the information given to parents at
discharge, including when to seek advice for prolonged seizures. In
some cases there was evidence that the parents had subsequently
been unsure of how or where to seek help if they were still worried.
This issue has been identiﬁed in other settings, including a 2004
UK-wide review of children’s deaths [19,20]. When a child is
discharged from hospital, parents need to be given very clear
advice on what signs to look for that might indicate some
deterioration in the child, how to respond to any concerns they
might have, and where and when to seek advice.
In three of the cases in this review, there was evidence of
inadequacies in responding to acute illness, including a failure to
recognise or respond appropriately to convulsive status epilepti-
cus. This has been identiﬁed elsewhere as a major contribution to
healthcare-amenable mortality [19–23]. Clinicians in hospital and
in the community need to be trained to recognise and respond to
acute childhood illness, to recognise the severely unwell child, and
to treat convulsive seizures appropriately and promptly. This
requires careful attention to the basics of securing the airway,
maintaining circulation, and prompt administration of benzodia-
zepines in appropriate doses through accessible routes. Prompt
and appropriate management can be promoted by the use of
individualised emergency care plans, which need to be prominent
and accessible to all carers and professionals. While it is recognised
that the risks of death are greatest in those children with complex
co-morbidities and difﬁcult to control epilepsies, it was notable
that four of the seven children who died in an episode of convulsive
status epilepticus had apparently well-controlled epilepsy. Parents
and professionals need to be aware that prolonged seizures carry a
signiﬁcant risk of mortality, and therefore need to be treated
promptly and adequately according to agreed national guidelines.
Parents also need to be aware of the potential risks of SUDEP,
particularly in those children with associated neuro-disability and
with poorly controlled seizures. The risks associated with seizures
need to be remembered, even in children with apparently well-
controlled epilepsy, and are a stimulus to optimising seizure
control.
The limited documentation following the child’s death was of
concern. This included a lack of information on any investigation
into the cause of death, outcomes of any post-mortem examina-
tion, classiﬁcation of the death, or support offered to the family.
This limits our ability to draw deﬁnitive conclusions about the
cause and circumstances of each death and of any factors that may
have contributed to the death. A further limitation of the study is
that we relied solely on health care records and did not approach
pathology departments or coroners for their records. The reality
that information following a death is rarely recorded in a child’s
health records is of concern as it limits the ability to understand
and learn from any individual death. Following any child’s death,
parents need support, including information about the cause of
their child’s death. It is important that this is carried out in a
coordinated manner and clearly documented in the child’s notes.
We would recommend that, for every child with epilepsy who dies,
the local clinical team, including the paediatric neurologist or
specialist in epilepsy, undertakes a case review, the results of
which should be communicated with the local Child Death
Overview Panel.
Although this was a national study, and likely to be broadly
representative of all children in the UK dying with epilepsy, the
overall response rate was 39%, and it was not possible to obtain full
notes for case notes review on all the notiﬁed children. Drawing on
the number of children’s deaths with epilepsy mentioned on the
death certiﬁcate, we would expect around 90–95 deaths within the
10-month period of the review. Thus our ﬁgures of 46 deaths
Table 5
Quality of care, compliance with deﬁned standards.
Phase of care/standards Numbera (%) with
evidence that
this standard had
been met
Initial diagnosis and management
1 Was the diagnosis established by a paediatric neurologist or specialist paediatrician
with training and expertise in epilepsy?
16/33 (48%)
2 Was there evidence that seizure type was considered in establishing the diagnosis? 20/33 (61%)
3 Was there evidence that an epilepsy syndrome was considered in establishing the
diagnosis?
13/33 (39%)
4 Was there evidence that aetiology was considered in establishing the diagnosis? 23/33 (70%)
5 Was there evidence that co-morbidities were considered in establishing the diagnosis? 23/33 (70%)
6 Was anti-epileptic drug treatment initiated by a paediatric neurologist or specialist
paediatrician with training and expertise in epilepsy?
9/33 (27%)
7 Were appropriate anti-epileptic drugs administered according to the seizure type,
epilepsy syndrome, co-medication and co-morbidity?
24/33 (73%)
8 Was there evidence that the child and family were given information about their
diagnosis and prognosis within six months of the diagnosis?
16/33 (48%)
Ongoing management
1 The child and family had access to a named individual to contact for advice and support 25/33 (76%)
2 The child and family have access to an epilepsy specialist nurse 16/33 (48%)
3 A named clinician was responsible for the ongoing management of the child/young
person’s epilepsy
27/33 (82%)
4 Where appropriate, the child/young person had been referred to a tertiary specialist 30/32 (94%)
5 The child’s epilepsy was reviewed at least annually (for uncomplicated epilepsy) or
more frequently (for epilepsy that was difﬁcult to control, or where other factors such as
co-morbidities, compliance indicated)
29/33 (88%)
6 Appropriate anti-epileptic drugs were administered according to the seizure type,
epilepsy syndrome, co-medication and co-morbidity
26/33 (79%)
7 For each anti-epileptic drugs, the child/young person was on an appropriate dose for
his/her age and weight
24/33 (73%)
8 Where a child had an anti-epileptic drugs withdrawn, the treatment was carried out
slowly over at least 2–3 months with a clear plan, and under the guidance of a specialist
3/9 (33%)
9 The child/young person had an appropriate individual care plan/treatment pathway 15/33 (45%)
10 There had been discussions around treatment plans and the management of seizures 28/33 (85%)
11 There had been discussions around medication, including concordance and adherence,
effectiveness, and side effects
16/33 (48%)
12 There had been discussions around support and academic progress 8/33 (24%)
13 There had been discussions around risks and hazards, including SUDEPb 14/33 (42%)
14 Where appropriate, the young person been involved in discussions about medication
and lifestyle issues
0/3 (0%)
Pre-hospital care
1 Was an appropriate trained person available to administer ﬁrst aid and emergency
treatment?
16/27 (59%)
2 Did the child/young person have an emergency care plan, and if so, was this followed? 3/19 (16%)
3 Was an ambulance called at an appropriate time? 11/26 (42%)
4 Did the ﬁrst responder/ambulance crew take appropriate steps to assess the situation,
secure the airway/breathing/circulation, and administer appropriate emergency
treatment, taking account of any treatment already given?
10/25 (40%)
5 Were buccal midazolam or other benzodiazepines given in an appropriate dose by the
ﬁrst responder/ambulance crew?
3/22 (14%)
Emergency department care
1 On arrival in the emergency department, were appropriate steps taken to assess and
secure the airway, breathing and circulation?
10/25 (40%)
2 Was appropriate medication given, taking account of treatment already given before
arrival?
10/25 (40%)
3 Was appropriate expertise (including an anaesthetist/intensivist) sought in a timely
manner?
12/25 (48%)
Intensive/high dependency care
1 If the child had ongoing seizure activity, was appropriate treatment with intravenous
midazolam or thiopental sodium given?
4/6 (67%)
2 Was adequate monitoring of the child in place throughout the intensive care stay? 4/6 (67%)
3 Was appropriate tertiary expertise consulted? 5/6 (83%)
aThe denominator is based on the number of children receiving care in this phase and for whom the particular standard applied; children who died in the community or did
not receive emergency or intensive/high dependency care were excluded from those ﬁgures; where a particular item was deemed inappropriate for that child, the child was
excluded from those ﬁgures.
b Of note, in only two out of the seven cases of SUDEP was there evidence in the notes that risks including SUDEP had previously been discussed with the family.
P. Sidebotham et al. / Seizure 30 (2015) 113–119118notiﬁed and 33 reviewed should not be interpreted as representa-
tive of all epilepsy deaths, and caution should be exercised in
interpreting data on the cause of death. Nevertheless, the number
notiﬁed and proportion reviewed are higher than in the previousNational Sentinel Audit. In spite of the relatively low response rate,
the ﬁndings are important, and may well reﬂect the better end of
any spectrum of care. It is possible that the clinicians who
responded to the review were those who were more engaged in
P. Sidebotham et al. / Seizure 30 (2015) 113–119 119epilepsy care, and that those cases not notiﬁed may have had poorer
quality care. Every attempt was made to ensure the review itself was
methodologically sound and reproducible, using a structured
proforma with pre-deﬁned explicit audit criteria, as well as a more
holistic approach to review, and by using pairs of paediatrician/
specialist nurse assessors. Nevertheless, the review was dependent
solely on the information recorded in the available notes, and this
was subject to the interpretation of the case assessors. We were not
able to seek the views of parents in this review, nor that of the
clinicians involved in the children’s care. However, it is our ﬁrm
belief that these limitations do not invalidate the ﬁndings of this
review. The aspects of poor quality care identiﬁed are unlikely to
represent isolated events and highlight system issues which may
continue to deny children optimal care and expose them to an
increased risk of premature death.
5. Conclusions
This UK-wide review of deaths in children with epilepsies has
identiﬁed a number of areas for improvement in the quality of care.
Although there has been clear progress in the overall quality of care
for these children, gaps in service provision remain, particularly in
relation to fragmentation of care for children with complex needs,
communication with parents and carers, and in the recognition of
and response to acute illness, including convulsive status
epilepticus. Fortunately, deaths from epilepsy are rare but a small
number do die each year. Some of these deaths are not directly
caused by the epilepsy, but are related to underlying co-
morbidities and may be unavoidable. Nevertheless, almost one-
quarter of all deaths reviewed in this national audit were
considered to be preventable. The clinical care of these children
needs to be carefully coordinated and supported by clear and
effective communication between individual clinicians, specialist
nurses and clinical teams, and with the young people and their
parents and carers.
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